Profile data is unavailable for this security.
About the company
The Calmer Co. International Limited is a health and wellness company with operations in Australia, Fiji, and the United States. The Company produces nutraceutical and functional beverage products designed to reduce anxiety, promote relaxation, improve sleep, and support sports recovery and performance. It works with farmers to source kava and hemp that is processed into active extracts for use in nutraceutical products, business to business (B2B) supply, and beverage applications. Its product range includes drinking powders, natural and flavored kava shots, concentrates and capsules, sold under the brands Fiji Kava, Taki Mai, and Danodan Hempworks. The Taki Mai and Fiji Kava brands are focused on expanding the distribution of kava as a natural alternative to alcohol and to synthetic sleep and anti-anxiety medicines. Its Danodan brand offers a patented range of certified organic tinctures and topicals, sold throughout the United States and online for relaxation, sleep, and recovery.
- Revenue in AUD (TTM)8.03m
- Net income in AUD-3.99m
- Incorporated2014
- Employees--
- LocationCalmer Co International Ltd96 Victoria Street, West EndBRISBANE 4101AustraliaAUS
- Phone+61 86489-1600
- Fax+61 86489-1601
- Websitehttps://www.thecalmerco.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anatara Lifesciences Ltd | 0.00 | -1.95m | 3.76m | -- | -- | 4.78 | -- | -- | -0.0096 | -0.0096 | 0.00 | 0.0025 | 0.00 | -- | -- | -- | -138.64 | -87.11 | -204.84 | -106.65 | -- | -- | -- | -- | -- | -- | 0.4319 | -- | -- | -- | -34.69 | -- | -- | -- |
| Acrux Ltd | 4.53m | -5.95m | 6.57m | 43.00 | -- | 6.38 | -- | 1.45 | -0.0176 | -0.0176 | 0.0129 | 0.0025 | 0.5594 | -- | 1.36 | -- | -73.45 | -48.30 | -148.89 | -61.75 | 100.00 | -- | -131.29 | -101.52 | -- | -18.59 | 0.7804 | -- | -44.08 | 3.32 | -2.50 | -- | -54.56 | -- |
| Nutritional Growth Solutions Ltd | 3.00m | -3.99m | 7.33m | -- | -- | -- | -- | 2.44 | -0.0433 | -0.0433 | 0.0322 | -0.0117 | 3.26 | 4.05 | 33.35 | -- | -433.20 | -130.49 | -- | -187.56 | 26.70 | 40.32 | -132.89 | -143.99 | 0.1206 | -19.99 | -- | -- | -16.86 | 15.95 | -0.2074 | -- | -- | -- |
| Zelira Therapeutics Ltd | 660.00 | -3.63m | 7.38m | 8.00 | -- | -- | -- | 11,176.12 | -0.3172 | -0.3172 | 0.00006 | -0.3749 | 0.0002 | 0.0102 | 0.003 | -- | -118.74 | -50.35 | -- | -56.97 | -1,236.36 | 43.05 | -583,283.30 | -2,379.12 | 0.0244 | -6.50 | -- | -- | -99.30 | -77.07 | 90.08 | -- | -- | -- |
| Immuron Ltd | 7.29m | -5.22m | 10.45m | 7.00 | -- | 0.9278 | -- | 1.43 | -0.0226 | -0.0226 | 0.0316 | 0.0345 | 0.5675 | 1.50 | 4.40 | 1,041,000.00 | -40.62 | -27.84 | -49.64 | -30.60 | 65.39 | 70.18 | -71.58 | -182.34 | 4.19 | -- | 0.00 | -- | 48.63 | 23.67 | 24.81 | -- | -- | -- |
| Tissue Repair Ltd | 3.02m | -4.24m | 12.40m | -- | -- | 0.891 | -- | 4.11 | -0.0701 | -0.0701 | 0.0499 | 0.2301 | 0.1777 | -- | 60.84 | -- | -24.96 | -24.25 | -26.50 | -25.27 | -- | -- | -140.49 | -518.54 | 22.40 | -- | 0.00 | -- | 236.85 | -- | -2.43 | -- | -- | -- |
| Epsilon Healthcare Ltd | 6.13m | -6.12m | 12.51m | -- | -- | -- | -- | 2.04 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| Calmer Co International Ltd | 8.03m | -3.99m | 13.76m | -- | -- | 7.12 | -- | 1.71 | -0.0015 | -0.0015 | 0.0029 | 0.0006 | 1.60 | 3.29 | 14.33 | -- | -79.73 | -109.82 | -171.17 | -197.50 | 42.49 | 41.18 | -49.69 | -128.71 | 1.22 | -11.32 | 0.5482 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Oncosil Medical Ltd | 1.26m | -15.10m | 15.73m | 2.00 | -- | 3.30 | -- | 12.47 | -1.38 | -1.38 | 0.1155 | 0.2182 | 0.182 | -- | 2.18 | -- | -217.79 | -97.54 | -382.54 | -117.83 | -78.62 | -54.05 | -1,196.80 | -1,258.41 | -- | -146.89 | 0.022 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
| Firebrick Pharma Ltd | 293.42k | -2.63m | 16.10m | -- | -- | 9.23 | -- | 54.87 | -0.0126 | -0.0126 | 0.0014 | 0.0069 | 0.1386 | 0.8696 | 0.4855 | -- | -124.44 | -98.41 | -143.50 | -109.28 | 35.72 | -- | -897.84 | -5,384.55 | 4.75 | -- | 0.00 | -- | 1,920.80 | -- | -124.04 | -- | -- | -- |
| TrivarX Ltd | 1.13m | -943.23k | 21.92m | 4.00 | -- | 0.9308 | -- | 19.35 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
